These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 21106381)
21. Development of acetylated HDD kit for preparation of 188Re-HDD/lipiodol. Lee YS; Jeong JM; Kim YJ; Chang YS; Lee HJ; Son M; Lee JW; Yoon HS; Kang WJ; Lee DS; Chung JK; Lee MC; Suh YG Appl Radiat Isot; 2007 Jan; 65(1):64-9. PubMed ID: 17010628 [TBL] [Abstract][Full Text] [Related]
22. Development of 4-hexadecyl-4,7-diaza-1,10-decanedithiol (HDD) kit for the preparation of the liver cancer therapeutic agent Re-188-HDD/lipiodol. Banka VK; Moon SH; Jeong JM; Seelam SR; Lee YS; Kim YJ; Lee DS; Chung JK Nucl Med Biol; 2015 Mar; 42(3):317-22. PubMed ID: 25537725 [TBL] [Abstract][Full Text] [Related]
23. Automated preparation of 188Re-labeled radiopharmaceuticals for endovascular radiation therapy. Oh SJ; Moon DH; Lee WW; Park SW; Hong MK; Park SJ; Shin DI; Lee HK Appl Radiat Isot; 2003 Oct; 59(4):225-30. PubMed ID: 14522229 [TBL] [Abstract][Full Text] [Related]
24. Mixed-ligand complexes of yttrium-90 dialkyldithiocarbamates with 1,10-phenanthroline as a possible agent for therapy of hepatocellular carcinoma. Lopez A; Noiret N; Garin E; Lepareur N Appl Radiat Isot; 2014 Dec; 94():241-246. PubMed ID: 25238135 [TBL] [Abstract][Full Text] [Related]
25. Use of the Oak Ridge National Laboratory tungsten-188/rhenium-188 generator for preparation of the rhenium-188 HDD/lipiodol complex for trans-arterial liver cancer therapy. Jeong JM; Knapp FF Semin Nucl Med; 2008 Mar; 38(2):S19-29. PubMed ID: 18243839 [TBL] [Abstract][Full Text] [Related]
26. Preparation of 177Lu-labeled oxine in lipiodol as a possible agent for therapy of hepatocellular carcinoma: a preliminary animal study. Subramanian S; Das T; Chakraborty S; Sarma HD; Banerjee S; Samuel G; Venkatesh M Cancer Biother Radiopharm; 2010 Oct; 25(5):539-43. PubMed ID: 20849309 [TBL] [Abstract][Full Text] [Related]
27. Automated preparation of Re-188 lipiodol for the treatment of hepatocellular carcinoma. Uccelli L; Pasquali M; Boschi A; Giganti M; Duatti A Nucl Med Biol; 2011 Feb; 38(2):207-13. PubMed ID: 21315276 [TBL] [Abstract][Full Text] [Related]
28. Fully automated preparation of [11C]choline and [18F]fluoromethylcholine using TracerLab synthesis modules and facilitated quality control using analytical HPLC. Shao X; Hockley BG; Hoareau R; Schnau PL; Scott PJ Appl Radiat Isot; 2011 Feb; 69(2):403-9. PubMed ID: 21115355 [TBL] [Abstract][Full Text] [Related]
29. A semi-automated system for concentration of rhenium-188 for radiopharmaceutical applications. Wunderlich G; Hartmann H; Andreeff M; Kotzerke J Appl Radiat Isot; 2008 Dec; 66(12):1876-80. PubMed ID: 18524608 [TBL] [Abstract][Full Text] [Related]
30. Infrared-based module for the synthesis of 68Ga-labeled radiotracers. Azhdarinia A; Yang DJ; Chao C; Mourtada F Nucl Med Biol; 2007 Jan; 34(1):121-7. PubMed ID: 17210469 [TBL] [Abstract][Full Text] [Related]
31. Direct radiolabeling of monoclonal antibodies with generator-produced rhenium-188 for radioimmunotherapy: labeling and animal biodistribution studies. Griffiths GL; Goldenberg DM; Knapp FF; Callahan AP; Chang CH; Hansen HJ Cancer Res; 1991 Sep; 51(17):4594-602. PubMed ID: 1873804 [TBL] [Abstract][Full Text] [Related]
32. Module-assisted synthesis of the bifunctional labelling agent N-succinimidyl 4-[(18)F]fluorobenzoate ([(18)F]SFB). Mäding P; Füchtner F; Wüst F Appl Radiat Isot; 2005 Sep; 63(3):329-32. PubMed ID: 15949940 [TBL] [Abstract][Full Text] [Related]
33. Automated module radiolabeling of peptides and antibodies with gallium-68, lutetium-177 and iodine-131. De Decker M; Turner JH Cancer Biother Radiopharm; 2012 Feb; 27(1):72-6. PubMed ID: 22149590 [TBL] [Abstract][Full Text] [Related]
34. 188Re-labeled bisphosphonates as potential bifunctional agents for therapy in patients with bone metastases. El-Mabhouh A; Mercer JR Appl Radiat Isot; 2005 Apr; 62(4):541-9. PubMed ID: 15701408 [TBL] [Abstract][Full Text] [Related]
35. Biologic dosimetry of 188Re-HDD/lipiodol versus 131I-lipiodol therapy in patients with hepatocellular carcinoma. De Ruyck K; Lambert B; Bacher K; Gemmel F; De Vos F; Vral A; de Ridder L; Dierckx RA; Thierens H J Nucl Med; 2004 Apr; 45(4):612-8. PubMed ID: 15073257 [TBL] [Abstract][Full Text] [Related]
36. Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer treatment. Knapp FF; Beets AL; Guhlke S; Zamora PO; Bender H; Palmedo H; Biersack HJ Anticancer Res; 1997; 17(3B):1783-95. PubMed ID: 9179235 [TBL] [Abstract][Full Text] [Related]
37. Fully automated synthesis of the M₁ receptor agonist [¹¹C]GSK1034702 for clinical use on an Eckert & Ziegler Modular Lab system. Huiban M; Pampols-Maso S; Passchier J Appl Radiat Isot; 2011 Oct; 69(10):1390-4. PubMed ID: 21605979 [TBL] [Abstract][Full Text] [Related]
38. Radiolabelling, quality control and radiochemical purity assessment of the Octreotide analogue 68Ga DOTA NOC. Di Pierro D; Rizzello A; Cicoria G; Lodi F; Marengo M; Pancaldi D; Trespidi S; Boschi S Appl Radiat Isot; 2008 Aug; 66(8):1091-6. PubMed ID: 18226535 [TBL] [Abstract][Full Text] [Related]
39. Simple, column purification technique for the fully automated radiosynthesis of [18F]fluoroazomycinarabinoside ([18F]FAZA). Nandy SK; Rajan MG Appl Radiat Isot; 2010 Oct; 68(10):1944-9. PubMed ID: 20478712 [TBL] [Abstract][Full Text] [Related]
40. Exploitation of nano alumina for the chromatographic separation of clinical grade 188Re from 188W: a renaissance of the 188W/188Re generator technology. Chakravarty R; Shukla R; Ram R; Venkatesh M; Tyagi AK; Dash A Anal Chem; 2011 Aug; 83(16):6342-8. PubMed ID: 21726091 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]